COR-201

N/A

Report date: 2025/01/26 19:17:46

Base Information

Drug NameCOR-201
Drug Alias Nameanti-SARS-CoV2 antibody (Corat Therapeutics)COR-201
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody human
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCorat Therapeutics Gmbh
China Registration ClassN/A

Develop Information

Active CompaniesCorat Therapeutics Gmbh
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A